_id
6910962dccc777a4e85d5b3e
Ticker
ELV
Name
Elevance Health Inc
Exchange
NYSE
Address
220 Virginia Avenue, Indianapolis, IN, United States, 46204
Country
USA
Sector
Healthcare
Industry
Healthcare Plans
Currency
USD
Website
https://www.elevancehealth.com
Description
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Last Close
360.22
Volume
570805
Current Price
359.07
Change
-0.3192493476209078
Last Updated
2025-11-30T17:49:20.120Z
Image
data:image/webp;base64,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
Ipo Date
2001-01-02T00:00:00.000Z
Market Cap
76168814592
Next Dividend Date
2025-12-19T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
1.71
Dividend Yield
1.904921046035592
Sentiment
0.9027973333333336
Sentiment Sources
75
Rating
4.4091
Target Price
387.1579
Strong Buy
13
Buy
5
Hold
4
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
50711000000
Cost Of Revenue
43520000000
Gross Profit
7191000000
Operating Expenses
5434000000
Operating Income
1757000000
Interest Expense
351000000
Pretax Income
1406000000
Net Income
1189000000
Eps
5.265721877767937
Dividends Per Share
381000000
Shares Outstanding
222238763
Income Tax Expense
219000000
EBITDA
2144000000
Operating Margin
3.4647315178166473
Total Other Income Expense Net
-351000000
Cash
8713000000
Short Term Investments
26283000000
Receivables
9535000000
Inventories
-
Total Current Assets
63778000000
Property Plant Equipment
4657000000
Total Assets
122749000000
Payables
23233000000
Short Term Debt
929000000
Long Term Debt
31173000000
Total Liabilities
78667000000
Equity
43953000000
Depreciation
387000000
Change In Working Capital
2003000000
Cash From Operations
1135000000
Capital Expenditures
360000000
Cash From Investing
-1224000000
Cash From Financing
243000000
Net Change In Cash
153000000
PE
13.7953
PB
1.8446523786772233
ROE
2.705162332491525
ROA
0.9686433290698906
FCF
775000000
Fcf Percent
0.01528268028632841
Piotroski FScore
3
Health Score
43
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
4
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
50711000000
Quarters > 0 > income Statement > cost Of Revenue
43520000000
Quarters > 0 > income Statement > gross Profit
7191000000
Quarters > 0 > income Statement > operating Expenses
5434000000
Quarters > 0 > income Statement > operating Income
1757000000
Quarters > 0 > income Statement > interest Expense
351000000
Quarters > 0 > income Statement > pretax Income
1406000000
Quarters > 0 > income Statement > net Income
1189000000
Quarters > 0 > income Statement > eps
5.265721877767937
Quarters > 0 > income Statement > dividends Per Share
381000000
Quarters > 0 > income Statement > shares Outstanding
225800000
Quarters > 0 > income Statement > income Tax Expense
219000000
Quarters > 0 > income Statement > EBITDA
2144000000
Quarters > 0 > income Statement > operating Margin
3.4647315178166473
Quarters > 0 > income Statement > total Other Income Expense Net
-351000000
Quarters > 0 > balance Sheet > cash
8713000000
Quarters > 0 > balance Sheet > short Term Investments
26283000000
Quarters > 0 > balance Sheet > receivables
9535000000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
63778000000
Quarters > 0 > balance Sheet > property Plant Equipment
4657000000
Quarters > 0 > balance Sheet > total Assets
122749000000
Quarters > 0 > balance Sheet > payables
23233000000
Quarters > 0 > balance Sheet > short Term Debt
929000000
Quarters > 0 > balance Sheet > long Term Debt
31173000000
Quarters > 0 > balance Sheet > total Liabilities
78667000000
Quarters > 0 > balance Sheet > equity
43953000000
Quarters > 0 > cash Flow > net Income
656000000
Quarters > 0 > cash Flow > depreciation
387000000
Quarters > 0 > cash Flow > change In Working Capital
2003000000
Quarters > 0 > cash Flow > cash From Operations
1135000000
Quarters > 0 > cash Flow > capital Expenditures
360000000
Quarters > 0 > cash Flow > cash From Investing
-1224000000
Quarters > 0 > cash Flow > cash From Financing
243000000
Quarters > 0 > cash Flow > net Change In Cash
153000000
Quarters > 0 > ratios > PE
5.265721877767937
Quarters > 0 > ratios > PB
1.8446523786772233
Quarters > 0 > ratios > ROE
2.705162332491525
Quarters > 0 > ratios > ROA
0.9686433290698906
Quarters > 0 > ratios > FCF
775000000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.01528268028632841
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
49776000000
Quarters > 1 > income Statement > cost Of Revenue
41999000000
Quarters > 1 > income Statement > gross Profit
49776000000
Quarters > 1 > income Statement > operating Expenses
47484000000
Quarters > 1 > income Statement > operating Income
2292000000
Quarters > 1 > income Statement > interest Expense
341000000
Quarters > 1 > income Statement > pretax Income
2292000000
Quarters > 1 > income Statement > net Income
1743000000
Quarters > 1 > income Statement > eps
7.719220549158547
Quarters > 1 > income Statement > dividends Per Share
385000000
Quarters > 1 > income Statement > shares Outstanding
225800000
Quarters > 1 > income Statement > income Tax Expense
548000000
Quarters > 1 > income Statement > EBITDA
3013000000
Quarters > 1 > income Statement > operating Margin
4.604628736740598
Quarters > 1 > income Statement > total Other Income Expense Net
6042000000
Quarters > 1 > balance Sheet > cash
8560000000
Quarters > 1 > balance Sheet > short Term Investments
25298000000
Quarters > 1 > balance Sheet > receivables
23125000000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
56983000000
Quarters > 1 > balance Sheet > property Plant Equipment
4641000000
Quarters > 1 > balance Sheet > total Assets
121938000000
Quarters > 1 > balance Sheet > payables
24433000000
Quarters > 1 > balance Sheet > short Term Debt
2008000000
Quarters > 1 > balance Sheet > long Term Debt
28178000000
Quarters > 1 > balance Sheet > total Liabilities
78087000000
Quarters > 1 > balance Sheet > equity
43722000000
Quarters > 1 > cash Flow > net Income
1744000000
Quarters > 1 > cash Flow > depreciation
380000000
Quarters > 1 > cash Flow > change In Working Capital
-1160000000
Quarters > 1 > cash Flow > cash From Operations
2054000000
Quarters > 1 > cash Flow > capital Expenditures
267000000
Quarters > 1 > cash Flow > cash From Investing
-687000000
Quarters > 1 > cash Flow > cash From Financing
-308000000
Quarters > 1 > cash Flow > net Change In Cash
1060000000
Quarters > 1 > ratios > PE
7.719220549158547
Quarters > 1 > ratios > PB
1.8543983806779196
Quarters > 1 > ratios > ROE
3.9865513928914504
Quarters > 1 > ratios > ROA
1.429414948580426
Quarters > 1 > ratios > FCF
1787000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.03590083574413372
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
48891000000
Quarters > 2 > income Statement > cost Of Revenue
4983000000
Quarters > 2 > income Statement > gross Profit
48891000000
Quarters > 2 > income Statement > operating Expenses
46094000000
Quarters > 2 > income Statement > operating Income
2797000000
Quarters > 2 > income Statement > interest Expense
344000000
Quarters > 2 > income Statement > pretax Income
2797000000
Quarters > 2 > income Statement > net Income
2183000000
Quarters > 2 > income Statement > eps
9.608274647887324
Quarters > 2 > income Statement > dividends Per Share
386000000
Quarters > 2 > income Statement > shares Outstanding
227200000
Quarters > 2 > income Statement > income Tax Expense
613000000
Quarters > 2 > income Statement > EBITDA
3514000000
Quarters > 2 > income Statement > operating Margin
5.720889325233683
Quarters > 2 > income Statement > total Other Income Expense Net
-35811000000
Quarters > 2 > balance Sheet > cash
7500000000
Quarters > 2 > balance Sheet > short Term Investments
25437000000
Quarters > 2 > balance Sheet > receivables
22181000000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
61121000000
Quarters > 2 > balance Sheet > property Plant Equipment
4617000000
Quarters > 2 > balance Sheet > total Assets
119717000000
Quarters > 2 > balance Sheet > payables
23943000000
Quarters > 2 > balance Sheet > short Term Debt
1893000000
Quarters > 2 > balance Sheet > long Term Debt
28110000000
Quarters > 2 > balance Sheet > total Liabilities
77097000000
Quarters > 2 > balance Sheet > equity
42503000000
Quarters > 2 > cash Flow > net Income
2184000000
Quarters > 2 > cash Flow > depreciation
373000000
Quarters > 2 > cash Flow > change In Working Capital
-1785000000
Quarters > 2 > cash Flow > cash From Operations
1017000000
Quarters > 2 > cash Flow > capital Expenditures
196000000
Quarters > 2 > cash Flow > cash From Investing
103000000
Quarters > 2 > cash Flow > cash From Financing
-1909000000
Quarters > 2 > cash Flow > net Change In Cash
-788000000
Quarters > 2 > ratios > PE
9.608274647887324
Quarters > 2 > ratios > PB
1.9194104886713879
Quarters > 2 > ratios > ROE
5.136108039432511
Quarters > 2 > ratios > ROA
1.8234670096978707
Quarters > 2 > ratios > FCF
821000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.016792456689370232
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
45442000000
Quarters > 3 > income Statement > cost Of Revenue
6012000000
Quarters > 3 > income Statement > gross Profit
45442000000
Quarters > 3 > income Statement > operating Expenses
44836000000
Quarters > 3 > income Statement > operating Income
606000000
Quarters > 3 > income Statement > interest Expense
340000000
Quarters > 3 > income Statement > pretax Income
606000000
Quarters > 3 > income Statement > net Income
418000000
Quarters > 3 > income Statement > eps
1.8087408048463869
Quarters > 3 > income Statement > dividends Per Share
373000000
Quarters > 3 > income Statement > shares Outstanding
231100000
Quarters > 3 > income Statement > income Tax Expense
193000000
Quarters > 3 > income Statement > EBITDA
1344000000
Quarters > 3 > income Statement > operating Margin
1.333568064785881
Quarters > 3 > income Statement > total Other Income Expense Net
-128688000000
Quarters > 3 > balance Sheet > cash
8288000000
Quarters > 3 > balance Sheet > short Term Investments
25201000000
Quarters > 3 > balance Sheet > receivables
19071000000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
52560000000
Quarters > 3 > balance Sheet > property Plant Equipment
5219000000
Quarters > 3 > balance Sheet > total Assets
116889000000
Quarters > 3 > balance Sheet > payables
22673000000
Quarters > 3 > balance Sheet > short Term Debt
2014000000
Quarters > 3 > balance Sheet > long Term Debt
29218000000
Quarters > 3 > balance Sheet > total Liabilities
75463000000
Quarters > 3 > balance Sheet > equity
41315000000
Quarters > 3 > cash Flow > net Income
413000000
Quarters > 3 > cash Flow > depreciation
398000000
Quarters > 3 > cash Flow > change In Working Capital
1514000000
Quarters > 3 > cash Flow > cash From Operations
706000000
Quarters > 3 > cash Flow > capital Expenditures
322000000
Quarters > 3 > cash Flow > cash From Investing
-1638000000
Quarters > 3 > cash Flow > cash From Financing
1408000000
Quarters > 3 > cash Flow > net Change In Cash
422000000
Quarters > 3 > ratios > PE
1.8087408048463869
Quarters > 3 > ratios > PB
2.0084975674694423
Quarters > 3 > ratios > ROE
1.0117390778167736
Quarters > 3 > ratios > ROA
0.35760422280967413
Quarters > 3 > ratios > FCF
384000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.008450332291712513
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
176810000000
Annuals > 0 > income Statement > cost Of Revenue
19750000000
Annuals > 0 > income Statement > gross Profit
176810000000
Annuals > 0 > income Statement > operating Expenses
168906000000
Annuals > 0 > income Statement > operating Income
7904000000
Annuals > 0 > income Statement > interest Expense
1185000000
Annuals > 0 > income Statement > pretax Income
7904000000
Annuals > 0 > income Statement > net Income
5980000000
Annuals > 0 > income Statement > eps
25.67625590382138
Annuals > 0 > income Statement > dividends Per Share
1508000000
Annuals > 0 > income Statement > shares Outstanding
232900000
Annuals > 0 > income Statement > income Tax Expense
1933000000
Annuals > 0 > income Statement > EBITDA
10482000000
Annuals > 0 > income Statement > operating Margin
4.470335388269894
Annuals > 0 > income Statement > total Other Income Expense Net
-129332000000
Annuals > 0 > balance Sheet > cash
8288000000
Annuals > 0 > balance Sheet > short Term Investments
25201000000
Annuals > 0 > balance Sheet > receivables
19071000000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
52560000000
Annuals > 0 > balance Sheet > property Plant Equipment
5219000000
Annuals > 0 > balance Sheet > total Assets
116889000000
Annuals > 0 > balance Sheet > payables
22673000000
Annuals > 0 > balance Sheet > short Term Debt
2014000000
Annuals > 0 > balance Sheet > long Term Debt
29218000000
Annuals > 0 > balance Sheet > total Liabilities
75463000000
Annuals > 0 > balance Sheet > equity
41315000000
Annuals > 0 > cash Flow > net Income
5971000000
Annuals > 0 > cash Flow > depreciation
1393000000
Annuals > 0 > cash Flow > change In Working Capital
-1719000000
Annuals > 0 > cash Flow > cash From Operations
5808000000
Annuals > 0 > cash Flow > capital Expenditures
1256000000
Annuals > 0 > cash Flow > cash From Investing
-5167000000
Annuals > 0 > cash Flow > cash From Financing
1193000000
Annuals > 0 > cash Flow > net Change In Cash
1762000000
Annuals > 0 > ratios > PE
25.67625590382138
Annuals > 0 > ratios > PB
1.9068317560208157
Annuals > 0 > ratios > ROE
14.474161926661019
Annuals > 0 > ratios > ROA
5.115964718664716
Annuals > 0 > ratios > FCF
4552000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.02574515016118998
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
171340000000
Annuals > 1 > income Statement > cost Of Revenue
124330000000
Annuals > 1 > income Statement > gross Profit
171340000000
Annuals > 1 > income Statement > operating Expenses
163625000000
Annuals > 1 > income Statement > operating Income
7715000000
Annuals > 1 > income Statement > interest Expense
1030000000
Annuals > 1 > income Statement > pretax Income
7715000000
Annuals > 1 > income Statement > net Income
5987000000
Annuals > 1 > income Statement > eps
25.219039595619208
Annuals > 1 > income Statement > dividends Per Share
1395000000
Annuals > 1 > income Statement > shares Outstanding
237400000
Annuals > 1 > income Statement > income Tax Expense
1724000000
Annuals > 1 > income Statement > EBITDA
10490000000
Annuals > 1 > income Statement > operating Margin
4.5027430839266955
Annuals > 1 > income Statement > total Other Income Expense Net
-1030000000
Annuals > 1 > balance Sheet > cash
6526000000
Annuals > 1 > balance Sheet > short Term Investments
29614000000
Annuals > 1 > balance Sheet > receivables
17865000000
Annuals > 1 > balance Sheet > inventories
-46332000000
Annuals > 1 > balance Sheet > total Current Assets
54005000000
Annuals > 1 > balance Sheet > property Plant Equipment
4943000000
Annuals > 1 > balance Sheet > total Assets
108928000000
Annuals > 1 > balance Sheet > payables
23021000000
Annuals > 1 > balance Sheet > short Term Debt
1874000000
Annuals > 1 > balance Sheet > long Term Debt
23246000000
Annuals > 1 > balance Sheet > total Liabilities
69523000000
Annuals > 1 > balance Sheet > equity
39306000000
Annuals > 1 > cash Flow > net Income
5987000000
Annuals > 1 > cash Flow > depreciation
1745000000
Annuals > 1 > cash Flow > change In Working Capital
-535000000
Annuals > 1 > cash Flow > cash From Operations
8061000000
Annuals > 1 > cash Flow > capital Expenditures
1296000000
Annuals > 1 > cash Flow > cash From Investing
-5572000000
Annuals > 1 > cash Flow > cash From Financing
-3349000000
Annuals > 1 > cash Flow > net Change In Cash
-861000000
Annuals > 1 > ratios > PE
25.219039595619208
Annuals > 1 > ratios > PB
2.0430194881188624
Annuals > 1 > ratios > ROE
15.23177123085534
Annuals > 1 > ratios > ROA
5.496291128084606
Annuals > 1 > ratios > FCF
6765000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.03948289949807401
Annuals > 1 > health Score
53
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
156595000000
Annuals > 2 > income Statement > cost Of Revenue
116642000000
Annuals > 2 > income Statement > gross Profit
156595000000
Annuals > 2 > income Statement > operating Expenses
148995000000
Annuals > 2 > income Statement > operating Income
7600000000
Annuals > 2 > income Statement > interest Expense
851000000
Annuals > 2 > income Statement > pretax Income
7600000000
Annuals > 2 > income Statement > net Income
5894000000
Annuals > 2 > income Statement > eps
24.27512355848435
Annuals > 2 > income Statement > dividends Per Share
1229000000
Annuals > 2 > income Statement > shares Outstanding
242800000
Annuals > 2 > income Statement > income Tax Expense
1712000000
Annuals > 2 > income Statement > EBITDA
10126000000
Annuals > 2 > income Statement > operating Margin
4.853283949040518
Annuals > 2 > income Statement > total Other Income Expense Net
-851000000
Annuals > 2 > balance Sheet > cash
7387000000
Annuals > 2 > balance Sheet > short Term Investments
25952000000
Annuals > 2 > balance Sheet > receivables
16044000000
Annuals > 2 > balance Sheet > inventories
-11381000000
Annuals > 2 > balance Sheet > total Current Assets
49383000000
Annuals > 2 > balance Sheet > property Plant Equipment
4920000000
Annuals > 2 > balance Sheet > total Assets
102755000000
Annuals > 2 > balance Sheet > payables
21203000000
Annuals > 2 > balance Sheet > short Term Debt
1765000000
Annuals > 2 > balance Sheet > long Term Debt
22349000000
Annuals > 2 > balance Sheet > total Liabilities
66425000000
Annuals > 2 > balance Sheet > equity
36243000000
Annuals > 2 > cash Flow > net Income
6019000000
Annuals > 2 > cash Flow > depreciation
1675000000
Annuals > 2 > cash Flow > change In Working Capital
253000000
Annuals > 2 > cash Flow > cash From Operations
8399000000
Annuals > 2 > cash Flow > capital Expenditures
1152000000
Annuals > 2 > cash Flow > cash From Investing
-4560000000
Annuals > 2 > cash Flow > cash From Financing
-1318000000
Annuals > 2 > cash Flow > net Change In Cash
2507000000
Annuals > 2 > ratios > PE
24.27512355848435
Annuals > 2 > ratios > PB
2.2660797395359102
Annuals > 2 > ratios > ROE
16.262450680131334
Annuals > 2 > ratios > ROA
5.73597391854411
Annuals > 2 > ratios > FCF
7247000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.046278616814074525
Annuals > 2 > health Score
59
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
138639000000
Annuals > 3 > income Statement > cost Of Revenue
102645000000
Annuals > 3 > income Statement > gross Profit
138639000000
Annuals > 3 > income Statement > operating Expenses
130644000000
Annuals > 3 > income Statement > operating Income
7995000000
Annuals > 3 > income Statement > interest Expense
798000000
Annuals > 3 > income Statement > pretax Income
7995000000
Annuals > 3 > income Statement > net Income
6158000000
Annuals > 3 > income Statement > eps
24.95137763371151
Annuals > 3 > income Statement > dividends Per Share
1104000000
Annuals > 3 > income Statement > shares Outstanding
246800000
Annuals > 3 > income Statement > income Tax Expense
1846000000
Annuals > 3 > income Statement > EBITDA
10095000000
Annuals > 3 > income Statement > operating Margin
5.766775582628265
Annuals > 3 > income Statement > total Other Income Expense Net
-104044000000
Annuals > 3 > balance Sheet > cash
4880000000
Annuals > 3 > balance Sheet > short Term Investments
26267000000
Annuals > 3 > balance Sheet > receivables
13440000000
Annuals > 3 > balance Sheet > inventories
-38483000000
Annuals > 3 > balance Sheet > total Current Assets
44587000000
Annuals > 3 > balance Sheet > property Plant Equipment
4547000000
Annuals > 3 > balance Sheet > total Assets
97460000000
Annuals > 3 > balance Sheet > payables
18488000000
Annuals > 3 > balance Sheet > short Term Debt
1874000000
Annuals > 3 > balance Sheet > long Term Debt
21157000000
Annuals > 3 > balance Sheet > total Liabilities
61332000000
Annuals > 3 > balance Sheet > equity
36060000000
Annuals > 3 > cash Flow > net Income
6095000000
Annuals > 3 > cash Flow > depreciation
1302000000
Annuals > 3 > cash Flow > change In Working Capital
784000000
Annuals > 3 > cash Flow > cash From Operations
8364000000
Annuals > 3 > cash Flow > capital Expenditures
1087000000
Annuals > 3 > cash Flow > cash From Investing
-9638000000
Annuals > 3 > cash Flow > cash From Financing
423000000
Annuals > 3 > cash Flow > net Change In Cash
-861000000
Annuals > 3 > ratios > PE
24.95137763371151
Annuals > 3 > ratios > PB
2.315101719356628
Annuals > 3 > ratios > ROE
17.077093732667777
Annuals > 3 > ratios > ROA
6.318489636774061
Annuals > 3 > ratios > FCF
7277000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.05248883791718059
Annuals > 3 > health Score
61
Valuation > metrics > PE
13.7953
Valuation > metrics > PB
1.8446523786772233
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
2.705162332491525
Profitability > metrics > ROA
1.8642792185393082
Profitability > metrics > Net Margin
0.023446589497347715
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.7897981935249017
Risk > metrics > Interest Coverage
5.005698005698005
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.639599370913004
Liquidity > metrics > Quick Ratio
2.639599370913004
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
22
Prev Profitabilities > 1
28
Prev Profitabilities > 2
6
Prev Risks > 0
57
Prev Risks > 1
63
Prev Risks > 2
37
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:25:28.991Z
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
1.71Next Payout:
Dec 19, 2025Yield:
1.9049 %Is Elevance Health (ELV) Quietly Repricing Its Risk Profile With Ratings Wins And AI Expansion? simplywall.st
Read more →Liontrust Investment Partners LLP Reduces Stock Position in Elevance Health, Inc. $ELV - MarketBeat
12/15/2025
Liontrust Investment Partners LLP Reduces Stock Position in Elevance Health, Inc. $ELV MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$387.1579
Analyst Picks
Strong Buy
13
Buy
5
Hold
4
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 73.77% of the total shares of Elevance Health Inc
1.
Vanguard Group Inc(10.1506%)
since
2025/06/30
2.
BlackRock Inc(9.4641%)
since
2025/03/31
3.
State Street Corp(4.7286%)
since
2025/03/31
4.
T. Rowe Price Associates, Inc.(3.5906%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(3.1535%)
since
2025/07/31
6.
Capital Research & Mgmt Co - Division 3(2.8813%)
since
2025/06/30
7.
Wellington Management Company LLP(2.8059%)
since
2025/06/30
8.
Sanders Capital, LLC(2.5869%)
since
2025/06/30
9.
Vanguard 500 Index Investor(2.4836%)
since
2025/07/31
10.
Geode Capital Management, LLC(2.2945%)
since
2025/03/31
11.
Artisan Partners Limited Partnership(1.6321%)
since
2025/06/30
12.
Arnhold & S. Bleichroeder Advisers, LLC(1.4212%)
since
2025/06/30
13.
UBS Asset Mgmt Americas Inc(1.3231%)
since
2025/06/30
14.
Morgan Stanley - Brokerage Accounts(1.3203%)
since
2025/03/31
15.
NORGES BANK(1.3112%)
since
2025/06/30
16.
Fidelity 500 Index(1.2719%)
since
2025/07/31
17.
Orbis Allan Gray Ltd(1.2683%)
since
2025/06/30
18.
iShares Core S&P 500 ETF(1.2072%)
since
2025/08/29
19.
SPDR® S&P 500® ETF(1.195%)
since
2025/08/29
20.
First Eagle Global A(1.1413%)
since
2025/07/31
21.
Northern Trust Corp(1.0846%)
since
2025/03/31
22.
Massachusetts Financial Services Company(1.0341%)
since
2025/06/30
23.
Harris Associates L.P.(1.0159%)
since
2025/06/30
24.
Baillie Gifford & Co Limited.(0.9934%)
since
2025/06/30
25.
Capital Group Wash Mutual Invtrs Comp(0.9878%)
since
2025/06/30
26.
American Funds Washington Mutual A(0.9878%)
since
2025/06/30
27.
Bank of America Corp(0.9791%)
since
2025/03/31
28.
Loomis Sayles Long Corp Disc Alpha(0.9712%)
since
2025/06/30
29.
Amvescap Plc.(0.9398%)
since
2025/03/31
30.
Vanguard Value Index Inv(0.8893%)
since
2025/07/31
31.
Vanguard Equity-Income Inv(0.8243%)
since
2025/06/30
32.
Vanguard Health Care Inv(0.7551%)
since
2025/06/30
33.
MFS Large Cap Value Equity(0.7465%)
since
2025/06/30
34.
MFS Value A(0.7421%)
since
2025/07/31
35.
Vanguard Windsor™ II Inv(0.7164%)
since
2025/06/30
36.
The Health Care Select Sector SPDR® ETF(0.684%)
since
2025/08/29
37.
Vanguard Institutional Index I(0.6065%)
since
2025/07/31
38.
Vanguard Dividend Appreciation ETF(0.5391%)
since
2025/07/31
39.
State St S&P 500® Indx SL Cl III(0.5364%)
since
2025/07/31
40.
T. Rowe Price U.S. Value Equity Tr-D(0.5019%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.